CNLCX
Price
$9.51
Change
-$0.04 (-0.42%)
Updated
Jun 5 closing price
Net Assets
13.13B
FILBX
Price
$9.51
Change
-$0.05 (-0.52%)
Updated
Jun 5 closing price
Net Assets
13.13B
Interact to see
Advertisement

CNLCX vs FILBX

Header iconCNLCX vs FILBX Comparison
Open Charts CNLCX vs FILBXBanner chart's image
CNLCX vs FILBX Comparison Chart in %
View a ticker or compare two or three
VS
CNLCX vs. FILBX commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNLCX is a Hold and FILBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNLCX (13.1B) and FILBX (13.1B) have equal amount of cash in the bank . FILBX pays higher dividends than CNLCX: FILBX (3.65) vs CNLCX (2.34). CNLCX was incepted earlier than FILBX: CNLCX (11 years) vs FILBX (9 years). CNLCX (1.44) is less costly to investors than FILBX (0.29). CNLCX (12.00) and FILBX (12.00) have comparable annual turnover. CNLCX has a lower initial minimum investment than FILBX: CNLCX (250) vs FILBX (1000000). FILBX annual gain was more profitable for investors over the last year : 4.92 vs. CNLCX (3.56). FILBX return over 5 years is better than : 3.42 vs. CNLCX (-2.40).
CNLCXFILBXCNLCX / FILBX
Total Expense Ratio1.440.29497%
Annual Report Gross Expense Ratio1.440.29497%
Fund Existence11 years9 years-
Gain YTD0.9511.48664%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B13.1B100%
Annual Yield % from dividends2.343.6564%
Returns for 1 year3.564.9272%
Returns for 3 years8.1712.1267%
Returns for 5 years-2.403.42-70%
Returns for 10 years14.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX65.23N/A
N/A
American Funds EUPAC R3
PHSZX46.53N/A
N/A
PGIM Jennison Health Sciences Z
WSBFX24.32N/A
N/A
Boston Trust Walden Balanced
JWWCX126.25N/A
N/A
Janus Henderson Global Research C
MATFX27.36N/A
N/A
Matthews Asia Innovators Investor